The second question on equity and inclusion is an additional prompt for their COVID-19 secondary added last year. Notice how they want you to shift your focus to others. They are asking what you learned from your pandemic experience that brought deeper insight to you on the plight of others...
fully human antibody, Ormutivimab for post-exposure prophylaxis. Clinical results showed Ormutivimab to be safe and effective, achieving its main and secondary efficacy endpoints after a single injection in exposed individuals. Ormuti
To test the hypothesis that inhibition of miR-148a could protect mice from thrombosis secondary to activation of platelets via FcγRIIA, anti-mouse CD9 antibody was used to induce HIT-like symptoms. Anti-CD9 Ab binds to platelet surface and lead to platelet activation by the interaction betwe...